The patient was suffering from a non-healing scalp defect and declining organ kidney and pancreas function, researchers said.
"Hopefully, this case and others like it will help to widen the narrow indications for this fascinating new field of reconstructive surgery," said Jesse Creed Selber of The University of Texas M D Anderson Cancer Centre and colleagues.
The experience may open the way to further procedures combining "vascularised composite allotransplantation" (VCA) with organ transplants, in patients who have already accepted the need for lifelong immunosuppressive therapy.
Face transplantation is the best-known type of VCA; hand transplantation is another example.
However, they also have a major drawback - the need for immunosuppressive drugs to prevent the recipient's immune system from rejecting the transplant.
Patients who also need or have already undergone organ transplantation have already accepted the risks of lifelong immunosuppressive therapy.
Two decades earlier, the 55-year-old patient had undergone kidney transplantation for diabetic kidney disease, but that kidney was now failing.
He also had a large, unstable wound of the scalp and skull - a complication of surgery and radiation therapy for a scalp tumour. An increased risk of cancers is one of the risks of long-term immunosuppressive treatment.
After 18 months, a suitable donor became available - providing not only basic immunologic compatibility but also a match in terms of skin colour and quality, hair pattern and head size.
The combined VCA and double-organ transplant procedure required 20 physicians and 15 hours in the operating room.
At the end of the procedure, both transplants were receiving good blood supply and the transplanted organs were functioning normally.
The fact that both the composite transplant and organs were from the same donor minimised the risk of rejecting tissues stimulated by a second donor's tissue.
The research was published in the journal of Plastic and Reconstructive Surgery.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
